Abstract
Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
Summary
”Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Switzerland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories - Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.
Scope
• Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the four market categories.
• Global corporate-level profiles of key companies operating within the Switzerland Drug Delivery Devicesmarket.
• Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Sunovion, Baxter International Inc., Teleflex Incorporated, B. Braun Melsungen AG and others.
Reasons to buy
• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Switzerland Drug Delivery Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Drug Delivery Devices In Switzerland 10
3.1 Drug Delivery Devices, Switzerland, Overall Revenue ($m), 2003-2017 10
3.2 Drug Delivery Devices, Switzerland, Category Volume (Units), 2003-2017 16
3.3 Drug Delivery Devices, Switzerland, Company Share (2009-2010) 21
4 Central Venous Catheters In Switzerland 23
4.1 Central Venous Catheters Overall Revenue (2003-2017) 23
4.2 Central Venous Catheters Overall Volume (2003-2017) 27
4.3 Central Venous Catheters Average Price (2003-2017) 30
4.4 Central Venous Catheters Distribution Share (2009-2010) 31
4.5 Central Venous Catheters, Switzerland, Company Share (2009-2010) 32
5 Infusion Systems In Switzerland 34
5.1 Infusion Systems Overall Revenue (2003-2017) 34
5.1.1 Syringe Pumps Revenue (2003-2010) 38
5.1.2 Ambulatory Infusion Pumps Revenue (2003-2010) 40
5.2 Infusion Systems Overall Volume (2003-2017) 43
5.2.1 Syringe Pumps Volume (2003-2010) 47
5.2.2 Ambulatory Infusion Pumps Volume (2003-2010) 50
5.3 Infusion Systems Average Price (2003-2017) 54
5.4 Infusion Systems Distribution Share (2009-2010) 55
5.5 Infusion Systems, Switzerland, Company Share (2009-2010) 56
6 Metered Dose Inhaler Devices In Switzerland 58
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 58
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 60
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 62
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 63
6.5 Metered Dose Inhaler Devices, Switzerland, Company Share (2009-2010) 64
7 Needle Free Injections In Switzerland 65
7.1 Needle Free Injections Overall Revenue (2003-2017) 65
7.2 Needle Free Injections Overall Volume (2003-2017) 67
7.3 Needle Free Injections Average Price (2003-2017) 69
7.4 Needle Free Injections Distribution Share (2009-2010) 70
7.5 Needle Free Injections, Switzerland, Company Share (2009-2010) 71
8 Overview of Key Companies in Switzerland Drug Delivery Devices Market 72
8.1 GlaxoSmithKline plc 72
8.1.1 Company Overview 72
8.2 AstraZeneca PLC 72
8.2.1 Company Overview 72
8.3 Teleflex Incorporated 73
8.3.1 Company Overview 73
8.4 Baxter International Inc. 73
8.4.1 Company Overview 73
8.5 B. Braun Melsungen AG 73
8.5.1 Company Overview 73
8.6 CareFusion Corporation 74
8.6.1 Company Overview 74
8.7 Hospira, Inc. 74
8.7.1 Company Overview 74
8.8 Medtronic, Inc. 75
8.8.1 Company Overview 75
8.9 Terumo Corporation 75
8.9.1 Company Overview 75
8.10 Fresenius Kabi AG 75
8.10.1 Company Overview 75
8.11 Smiths Medical 76
8.11.1 Company Overview 76
8.12 Edwards Lifesciences Corporation 76
8.12.1 Company Overview 76
8.13 3M Health Care 76
8.13.1 Company Overview 76
8.14 Consort Medical plc 77
8.14.1 Company Overview 77
8.15 Becton, Dickinson and Company 77
8.15.1 Company Overview 77
8.16 Codman & Shurtleff, Inc. 77
8.16.1 Company Overview 77
8.17 Cook Medical Incorporated 78
8.17.1 Company Overview 78
8.18 INJEX - Equidyne Systems 78
8.18.1 Company Overview 78
8.19 Antares Pharma, Inc. 78
8.19.1 Company Overview 78
8.20 Bioject Medical Technologies Inc. 79
8.20.1 Company Overview 79
9 Appendix 80
9.1 Global Markets Direct Research Methodology 80
9.2 Definitions of Markets Covered in the Report 81
9.2.1 Drug Delivery Devices 81
9.3 Secondary Research 83
9.4 Primary Research 84
9.5 Models 84
9.6 Forecasts 85
9.7 Expert Panel Validation 85
9.8 Currency Conversion 85
9.9 Contact Us 86
9.10 Disclaimer 86
List of Tables
1.1 List of Tables
Table 1: Drug Delivery Devices, Switzerland, Overall Revenue ($m), 2003-2017 11
Table 2: Drug Delivery Devices, Switzerland, Overall Revenue ($m), Historic, 2003-2010 13
Table 3: Drug Delivery Devices, Switzerland, Overall Revenue ($m), Forecast, 2010-2017 15
Table 4: Drug Delivery Devices, Switzerland, Category Volume (Units), 2003-2017 16
Table 5: Drug Delivery Devices, Switzerland, Category Volume (Units), Historic, 2003-2010 18
Table 6: Drug Delivery Devices, Switzerland, Category Volume (Units), Forecast, 2010-2017 20
Table 7: Drug Delivery Devices, Switzerland, Company Share by Revenue ($m), 2009-2010 22
Table 8: Central Venous Catheters, Switzerland, Revenue ($m) by Segment, Historic, 2003-2010 24
Table 9: Central Venous Catheters, Switzerland, Revenue ($m) by Segment, Forecast, 2010-2017 26
Table 10: Central Venous Catheters, Switzerland, Volume (Units) by Segment, Historic, 2003-2010 28
Table 11: Central Venous Catheters, Switzerland, Volume (Units) by Segment, Forecast, 2010-2017 29
Table 12: Central Venous Catheters, Switzerland, Average Price ($), Historic, 2003-2010 30
Table 13: Central Venous Catheters, Switzerland, Average Price ($), Forecast, 2010-2017 30
Table 14: Central Venous Catheters, Switzerland, Distribution Share by Revenue ($m), 2009-2010 31
Table 15: Central Venous Catheters, Switzerland, Company Share by Revenue ($m), 2009-2010 33
Table 16: Infusion Systems, Switzerland, Revenue ($m) by Segment, Historic, 2003-2010 35
Table 17: Infusion Systems, Switzerland, Revenue ($m) by Segment, Forecast, 2010-2017 37
Table 18: Syringe Pumps, Switzerland, Revenue ($m) by Sub-Segment, Historic, 2003-2010 38
Table 19: Syringe Pumps, Switzerland, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 39
Table 20: Ambulatory Infusion Pumps, Switzerland, Revenue ($m) by Sub-Segment, Historic, 2003-2010 41
Table 21: Ambulatory Infusion Pumps, Switzerland, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 42
Table 22: Infusion Systems, Switzerland, Volume (Units) by Segment, Historic, 2003-2010 44
Table 23: Infusion Systems, Switzerland, Volume (Units) by Segment, Forecast, 2010-2017 46
Table 24: Syringe Pumps, Switzerland, Volume (Units) by Sub-Segment, Historic, 2003-2010 48
Table 25: Syringe Pumps, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2010-2017 49
Table 26: Ambulatory Infusion Pumps, Switzerland, Volume (Units) by Sub-Segment, Historic, 2003-2010 51
Table 27: Ambulatory Infusion Pumps, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2010-2017 53
Table 28: Infusion Systems, Switzerland, Average Price ($), Historic, 2003-2010 54
Table 29: Infusion Systems, Switzerland, Average Price ($), Forecast, 2010-2017 54
Table 30: Infusion Systems, Switzerland, Distribution Share by Revenue ($m), 2009-2010 55
Table 31: Infusion Systems, Switzerland, Company Share by Revenue ($m), 2009-2010 57
Table 32: Metered Dose Inhaler Devices, Switzerland, Revenue ($m) Historic, 2003-2010 58
Table 33: Metered Dose Inhaler Devices, Switzerland, Revenue ($m) Forecast, 2010-2017 59
Table 34: Metered Dose Inhaler Devices, Switzerland, Volume (Units) Historic, 2003-2010 60
Table 35: Metered Dose Inhaler Devices, Switzerland, Volume (Units), Forecast, 2010-2017 61
Table 36: Metered Dose Inhaler Devices, Switzerland, Average Price ($), Historic, 2003-2010 62
Table 37: Metered Dose Inhaler Devices, Switzerland, Average Price ($), Forecast, 2010-2017 62
Table 38: Metered Dose Inhaler Devices, Switzerland, Distribution Share by Revenue ($m), 2009-2010 63
Table 39: Metered Dose Inhaler Devices, Switzerland, Company Share by Revenue ($m), 2009-2010 64
Table 40: Needle Free Injections, Switzerland, Revenue ($m) Historic, 2003-2010 65
Table 41: Needle Free Injections, Switzerland, Revenue ($m) Forecast, 2010-2017 66
Table 42: Needle Free Injections, Switzerland, Volume (Units) Historic, 2003-2010 67
Table 43: Needle Free Injections, Switzerland, Volume (Units) Forecast, 2010-2017 68
Table 44: Needle Free Injections, Switzerland, Average Price ($), Historic, 2003-2010 69
Table 45: Needle Free Injections, Switzerland, Average Price ($), Forecast, 2010-2017 69
Table 46: Needle Free Injections, Switzerland, Distribution Share by Revenue ($m), 2009-2010 70
Table 47: Needle Free Injections, Switzerland, Company Share by Revenue ($m), 2009-2010 71
Table 48: USD to Local Currency, Switzerland, Average Actual Rate 2003-2010 85
List of Figures
1.2 List of Figures
Figure 1: Drug Delivery Devices, Switzerland, Overall Revenue ($m), 2003-2017 10
Figure 2: Drug Delivery Devices, Switzerland, Overall Revenue ($m), Historic, 2003-2010 12
Figure 3: Drug Delivery Devices, Switzerland, Overall Revenue ($m), Forecast, 2010-2017 14
Figure 4: Drug Delivery Devices, Switzerland, Category Volume (Units), 2003-2017 16
Figure 5: Drug Delivery Devices, Switzerland, Category Volume (Units), Historic, 2003-2010 17
Figure 6: Drug Delivery Devices, Switzerland, Category Volume (Units), Forecast, 2010-2017 19
Figure 7: Drug Delivery Devices, Switzerland, Company Share (%), 2010 21
Figure 8: Central Venous Catheters, Switzerland, Revenue ($m) by Segment, Historic, 2003-2010 23
Figure 9: Central Venous Catheters, Switzerland, Revenue ($m) by Segment, Forecast, 2010-2017 25
Figure 10: Central Venous Catheters, Switzerland, Volume (Units) by Segment, Historic, 2003-2010 27
Figure 11: Central Venous Catheters, Switzerland, Volume (Units) by Segment, Forecast, 2010-2017 29
Figure 12: Central Venous Catheters, Switzerland, Company Share (%), 2010 32
Figure 13: Infusion Systems, Switzerland, Revenue ($m) by Segment, Historic, 2003-2010 34
Figure 14: Infusion Systems, Switzerland, Revenue ($m) by Segment, Forecast, 2010-2017 36
Figure 15: Syringe Pumps, Switzerland, Revenue ($m) by Sub-Segment, Historic, 2003-2010 38
Figure 16: Syringe Pumps, Switzerland, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 39
Figure 17: Ambulatory Infusion Pumps, Switzerland, Revenue ($m) by Sub-Segment, Historic, 2003-2010 40
Figure 18: Ambulatory Infusion Pumps, Switzerland, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 42
Figure 19: Infusion Systems, Switzerland, Volume (Units) by Segment, Historic, 2003-2010 43
Figure 20: Infusion Systems, Switzerland, Volume (Units) by Segment, Forecast, 2010-2017 45
Figure 21: Syringe Pumps, Switzerland, Volume (Units) by Sub-Segment, Historic, 2003-2010 47
Figure 22: Syringe Pumps, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2010-2017 49
Figure 23: Ambulatory Infusion Pumps, Switzerland, Volume (Units) by Sub-Segment, Historic, 2003-2010 50
Figure 24: Ambulatory Infusion Pumps, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2010-2017 52
Figure 25: Infusion Systems, Switzerland, Company Share (%), 2010 56
Figure 26: Metered Dose Inhaler Devices, Switzerland, Revenue ($m) Historic, 2003-2010 58
Figure 27: Metered Dose Inhaler Devices, Switzerland, Revenue ($m) Forecast, 2010-2017 59
Figure 28: Metered Dose Inhaler Devices, Switzerland, Volume (Units) Historic, 2003-2010 60
Figure 29: Metered Dose Inhaler Devices, Switzerland, Volume (Units), Forecast, 2010-2017 61
Figure 30: Metered Dose Inhaler Devices, Switzerland, Company Share (%), 2010 64
Figure 31: Needle Free Injections, Switzerland, Revenue ($m) Historic, 2003-2010 65
Figure 32: Needle Free Injections, Switzerland, Revenue ($m) Forecast, 2010-2017 66
Figure 33: Needle Free Injections, Switzerland, Volume (Units) Historic, 2003-2010 67
Figure 34: Needle Free Injections, Switzerland, Volume (Units) Forecast, 2010-2017 68
Figure 35: Needle Free Injections, Switzerland, Company Share (%), 2010 71
Figure 36: Global Markets Direct Methodology 80
